Blischak Matthew P. [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Blischak Matthew P.

Create: Alert

All | News | Filings

Date Filed

Type

Description

06/09/2023

Blischak Matthew P. (CEO) has filed a Form 4 on Finch Therapeutics Group, Inc.

Txns:

Granted 962,899 options to buy @ $0.285, valued at $274.4k

05/16/2023

Blischak Matthew P. (CEO) has filed a Form 3 on Finch Therapeutics Group, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy